Symbol="PEPG"
AssetType="Common Stock"
Name="PepGen Ltd"
Description="PepGen Inc., a clinical-stage biotechnology company, is focused on the development of oligonucleotide therapeutics for use in the treatment of serious neurological and neuromuscular diseases. The company is headquartered in Cambridge, Massachusetts."
CIK="1835597"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1 MARINA PARK DRIVE, SUITE 900, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="176702000"
EBITDA="-71825000"
PERatio="None"
PEGRatio="None"
BookValue="6.93"
DividendPerShare="0"
DividendYield="0"
EPS="-2.68"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.272"
ReturnOnEquityTTM="-0.479"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.68"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="24.4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.665"
EVToRevenue="-"
EVToEBITDA="-2.165"
Beta="None"
num_52WeekHigh="20"
num_52WeekLow="4.32"
num_50DayMovingAverage="12.24"
num_200DayMovingAverage="13.51"
SharesOutstanding="23782300"
DividendDate="None"
ExDividendDate="None"
symbol="PEPG"
open="7.45"
high="7.73"
low="7.08"
price="7.25"
volume="75754.00"
latest_trading_day="2023-07-19"
previous_close="7.43"
change="-0.18"
change_percent="-2.4226%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="83"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="17"
Volume_recent_avg="52334"
Change_recent_avg="-0.16"
Delta_recent_avg="1.33"
Variance_recent_avg="0.66"
Change_ratio_recent_avg="-1.51"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="17"
Aroon_momentum_negative="83"
image_negative_thumbnail_id_1="516"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0089.jpeg"
image_negative_thumbnail_id_2="112"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0064.jpeg"
image_neutral_thumbnail_id_1="569"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_neutral_thumbnail_id_2="575"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0024.jpeg"
image_positive_thumbnail_id_1="618"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0090.jpeg"
image_positive_thumbnail_id_2="662"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0046.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1175"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
